Senem Karabulut

2PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 20, 2025
Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?

Ceren Canbey, Sena Şen, Senem Karabulut

|Sep 09, 2022
Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Izzet Dogan, Didem Tastekin, Senem Karabulut

Pageof 1

Frequent Collaborators

1 joint publications

Izzet Dogan

1 joint publications

Didem Tastekin

1 joint publications

Burak Sakar

1 joint publications

Ceren Canbey